// App-Quantinova.ai

: NEONATAL OVARIAN RESERVE FOLLOWING CHEMOTHERAPY EXPOSURE, EX VIVO MURINE MODEL

Researchers

Presenter

  • Meghan C.H. Ozcan

Principal Investigators

  • Morgan F. Woodman

  • Julienne Chaqour

  • Kathryn J. Grive

Medical Centers

  • Pediatrics, Women & Infants Hospital of Rhode Island, Providence, RI

  • Women and Infants Hospital in Rhode Island, Providence, RI

  • Brown University Urology, Providence, RI

  • Pediatrics, Women & Infants Hospital of Rhode Island, Providence, RI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Doxorubicin

  • Paclitaxel

  • Docetaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved